Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-022894

CEO sold 55,684 shares at $3.09 ($171,841)

  • CEO acquired 76,490 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-21 Exercise or conversion : show line 1 in the form +76,490 $1.69 $129,345 1,117,408 D
2026-05-21 Sale : show line 2 in the form −55,684 $3.09 $171,841 1,061,724 D
Open-market sales · 55,684 sh · avg $3.09 · $171,841

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-21 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −76,490 $1.69 $129,345 0 D
Loading xslF345X06/form4.xml…